Novel radiotracer advantageous for imaging of neuroendocrine tumor patients
(Society of Nuclear Medicine and Molecular Imaging) For neuroendocrine cancer patients with liver metastases, a new radiopharmaceutical, 68Ga-DOTA-JR11, has shown excellent imaging performance in tumor detection, staging and restaging, providing important information to guide treatment.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news
More News: Brain | Cancer | Cancer & Oncology | International Medicine & Public Health | Liver | Neurology | Nuclear Medicine | Urology & Nephrology